relacorilant
corcept therapeutics
['ovarian', 'gyn', 'relacorilant']
in asco gyn oral session: intermittent #relacorilant + nab-paclitaxel improves pfs over nab-paclitexel alone in platinum resistant/refractory #ovarian cancer (randomized phase 2). #gynsm #asco22 
CME experts Sara Fagerlie, PhD, CHCP and Mindy Tanzola, PhD founded Front Row CME to help clinicians and educators manage the oncology information deluge.